在我国创新药行业加速发展的浪潮中，翰森制药凭借深厚的研发积累与战略布局，已站稳脚跟并建立优势。从亮眼的销售数据到近期密集的利好消息，这家企业正以强劲势头在国内外创新药市场持续发力。从业绩表现来看，翰森制药创新药业务已成为核心增长引擎。据公司半年报显示，今年上半年其创新药与合作产品销售收入达 61.45 亿元人民币，同比增长 22.1%，占总收入比重高达 82.7%。目前，公司在中国产生销售收入的...
Source Link在我国创新药行业加速发展的浪潮中，翰森制药凭借深厚的研发积累与战略布局，已站稳脚跟并建立优势。从亮眼的销售数据到近期密集的利好消息，这家企业正以强劲势头在国内外创新药市场持续发力。从业绩表现来看，翰森制药创新药业务已成为核心增长引擎。据公司半年报显示，今年上半年其创新药与合作产品销售收入达 61.45 亿元人民币，同比增长 22.1%，占总收入比重高达 82.7%。目前，公司在中国产生销售收入的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.